Coltin Krauss

Senior Director, Financial Planning & Analysis at Parker Institute for Cancer Immunotherapy

Coltin Krauss is Senior Director of Financial Planning & Analysis at the Parker Institute for Cancer Immunotherapy (PICI), having worked previously as a project budgeting consultant for the organization. In his expanded role, he will concentrate on corporate-wide strategic financial planning, budgeting, analysis and reporting.

Before joining PICI, Coltin was a finance consultant at Myovant Sciences, where he helped launch their first product, ORGOVYX, a prescription medicine for advanced prostate cancer. Before that, he served in various R&D finance roles

at Genentech/Roche Group.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy (PICI) is radically changing the way cancer research is done. Founded in 2016 through a $250 million gift from Silicon Valley entrepreneur and philanthropist Sean Parker, the San Francisco-based nonprofit is an unprecedented collaboration between the country's leading immunotherapy researchers and cancer centers, including Memorial Sloan Kettering Cancer Center, Stanford Medicine, the University of California, Los Angeles, the University of California, San Francisco, the University of Pennsylvania and The University of Texas MD Anderson Cancer Center.


Industries

Employees

51-200

Links